Posted by Michael Wonder on 08 Mar 2022
Key considerations in the health technology assessment of advanced therapy medicinal products in Scotland, The Netherlands and England
8 March 2022 - Advanced therapy medicinal products are highly innovative therapies. Their costs and uncertain value claims have raised concerns among health technology assessment bodies and payers.
Little is known about how underlying considerations in health technology assessment of advanced therapy medicinal products shape assessment and reimbursement recommendations.
